Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Clinical Strategies for Managing Dyslipidemias
Ulf G. Bronas
,
Dereck Salisbury
Academics (Nursing)
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical Strategies for Managing Dyslipidemias'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lipoproteins
100%
Dyslipidemia
100%
Clinical Strategies
100%
Cardiovascular Risk Factors
60%
Statins
40%
Mixed Dyslipidemia
40%
High-density Lipoprotein Cholesterol (HDL-C)
40%
C-level
40%
Total Cholesterol
40%
Niacin
20%
Pharmacological Therapy
20%
Combination Therapy
20%
Cardiovascular Prevention
20%
Physical Inactivity
20%
Diet-induced Obesity
20%
Triglycerides
20%
Cardiovascular Events
20%
Lipid Levels
20%
Diet Plan
20%
Lifestyle Factors
20%
Aggressive Treatment
20%
Blood Levels
20%
Cholestyramine
20%
Aggressive Therapy
20%
Dietary Habits
20%
Fibrates
20%
Regular Aerobic Exercise
20%
Therapeutic Lifestyle Changes
20%
3-hydroxy-3-methylglutaryl-CoA Reductase
20%
Statin Drugs
20%
Reductase Inhibitors
20%
HMG-CoA Reductase
20%
Lifestyle Therapy
20%
Secondary Prevention of Cardiovascular Diseases
20%
Low-density Lipoprotein Triglyceride
20%
Pharmacology, Toxicology and Pharmaceutical Science
Dyslipidemia
100%
Lipoprotein
85%
Cardiovascular Disease
57%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
28%
Triacylglycerol
28%
High Density Lipoprotein
28%
Cholesterol
28%
Pharmacotherapy
14%
Nicotinic Acid
14%
Statin (Protein)
14%
Lipid
14%
Coenzyme A
14%
Oxidoreductase
14%
Colestyramine
14%
Fibric Acid Derivative
14%
Hydroxymethylglutaryl Coenzyme A Reductase
14%
Combination Therapy
14%